Ready to Improve Your Biomarker Intelligence?

TALK TO A BIOMARKER STRATEGIST
Posts From the monthly archives: "September 2016"

September is World Alzheimer’s Month! In honor of this we created an infographic highlighting some important alzheimer’s facts, stats, and how alzheimer’s research can benefit from the use of biomarkers. To learn more about Amplion and BiomarkerBase…(Read More)

This is the first of a 5 installment series covering what we’ve learned about effective biomarker knowledge management over the last few years. The topic will be driven by a “maturity model” that we’ve developed while working with our pharmaceutical, diagnostic and consulting clients. The model outlines the common practice of our clients…(Read More)

In BiomarkerBase we track biomarker use in trials, including those biomarkers used as patient selection criteria in particular clinical trials. We used this capability in a report we recently co-authored with BIO and Informa on clinical trials success rates (spoiler: patient selection biomarkers increase likelihood of approval significantly). For this chart of the week…(Read More)

In May we released a report co-authored with BIO and BioMedTracker. One of the key take-aways from the report is that patient selection biomarkers, if used successfully, can triple the Likelihood of Approval (LOA) for clinical studies.  Here is the data: Share this Image On Your Site Please include attribution to amplion.com…(Read More)